SNX-2112
Catalog No: 179815
CAS Number: 908112-43-6
Purity: 98.0%
SNX-2112, also known as PF 04928473, is an Hsp90 inhibitor which is currently undergoing multiple phase 1 clinical trials.
For research use only. We do not sell to patients.
Chemical Information
| Name | SNX-2112 |
|---|---|
| Iupac Chemical Name | 4-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)-2-(((1r,4r)-4-hydroxycyclohexyl)amino)benzamide |
| Synonyms | SNX2112; SNX-2112; SNX 2112; PF 04928473; PF-04928473; PF04928473. |
| Molecular Formula | C23H27F3N4O3 |
| Molecular Weight | 464.48 |
| Smile | CC1(Cc2c(c(nn2c3ccc(c(c3)N[C@@H]4CC[C@H](CC4)O)C(=O)N)C(F)(F)F)C(=O)C1)C |
| InChiKey | |
| InChi | |
| CAS Number | 908112-43-6 |
| MDL | MFCD16038907 |
| Related CAS |
Ordering Information
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | off-white solid |
|---|---|
| Purity | 98.0% |
| Storage | -20 ℃ for 3 years |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature |
| HS Code |
Coming soon.
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |
Not available
Chemical Structure
